Keith Loria
Keith Loria is a contributing writer to Medical Economics.
Researchers validate robotic cystectomy quality tool
A team from Roswell Park Cancer Institute has developed and validated a quality assessment tool based on prospectively collected data on robot-assisted cystectomy.
Physician’s political party could affect healthcare, study finds
Physician’s political party could affect healthcare, study finds
The care you receive from your doctor could depend on whether he or she is a Democrat or Republican
Testosterone solution yields improved sex drive, energy
A new study finds that treatment with testosterone solution 2% can be effective for hypogonadism with no new safety concerns.
SBRT yields excellent Ca control, low rate of severe toxicity
Results from a multicenter study show progression-free survival in 97% of low- and intermediate-risk prostate cancer patients.
Researchers ID markers of resistance to two PCa therapies
Findings from a recent study indicate that CTCs detected in blood have the potential to reveal important genetic information that could guide treatment selection.
Telemedicine up for heated debate
Telemedicine up for heated debate
The states of Arkansas and Texas rate last and next-to-last in telemedicine practice standards, an issue that has gained prominence in the medical community in recent years, according to a recent report by the American Telemedicine Association.
Hospital ownership of physician practices on the rise
Hospital ownership of physician practices on the rise
The number of physician practices owned by hospitals has increased 86% over the past 4 years, which also resulted in a 50% rise in the number of physicians employed by hospitals, according to a recent study.
Advocacy group aims to close malpractice loophole in NPDB
Advocacy group aims to close malpractice loophole in NPDB
A loophole exists that allows a physician to avoid being reported to the NPDB if a malpractice plaintiff agrees to dismiss the practitioner from a lawsuit or claim, leaving a hospital or other corporate entity as the sole defendant.
Active surveillance: A potential role in metastatic RCC?
Results from a recent prospective trial suggest that active surveillance may be suitable for some patients with advanced renal cell carcinoma.
Will Aetna, Humana merger go through?
Will Aetna, Humana merger go through?
Despite concessions, DOJ on mission to block merger of health insurers.

Poll